A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
S8 Ep2: Exploring AI Innovation: insitro CEO Daphne Koller On AI In Drug Discovery
MP3•Episode home
Manage episode 469784481 series 3317342
Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.
49 episodes
MP3•Episode home
Manage episode 469784481 series 3317342
Content provided by The Minor Consult and Stanford Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Minor Consult and Stanford Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.
49 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.